Skip to content

Retrospective Comparative Study of Routine Lower Neck CT in the Staging and Diagnosis of Lung Cancer Across Two Cohorts

Retrospective Comparative Study of Routine Lower Neck CT in the Staging and Diagnosis of Lung Cancer Across Two Cohorts

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03522090
Enrollment
164
Registered
2018-05-11
Start date
2018-07-01
Completion date
2019-01-30
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Supraclavicular Lymphadenopathy

Brief summary

This is a study comparing routine inclusion of the lower neck in initial CT thorax in patients with suspected lung cancer to not including it. The study aims to assess whether such an intervention reduces the number of invasive investigations required to achieve a final diagnosis and clinical stage and whether it improves the detection of cervical lymph nodes involvement by lung cancer.

Detailed description

Two practices currently exist regarding the role of lower neck CT in patients with suspected lung cancer but with little evidence for either. Routine lower neck CT is potentially associated with benefits of higher detection of neck lymphadenopathy leading to better staging, less invasive procedure with positive implications for patients experience and care. The potential harms are delay in diagnosis due to false positive findings and radiation exposure. There is limited evidence in this area so this study will potentially provide evidence to inform health policy decisions based on the risk benefit balance. This is a retrospective comparative study to assess the real-life impact of routine lower neck CT on the diagnostic and staging work up of patients with suspected lung cancer across two cohorts.

Interventions

DIAGNOSTIC_TESTlower neck CT

Computerised tomography of the lower neck done as part of initial CT thorax and lower abdomen

Sponsors

University Hospital Plymouth NHS Trust
CollaboratorOTHER
University College Hospital Galway
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Male or female age \> 18 years * Pathologically confirmed primary lung cancer * Intrathoracic N2 and or N3 disease on CT defined as lymph node with short diameter \> 10 mm

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Proportion of pathologically confirmed malignant supraclavicular lymph node60 days from initial CTevidence of malignancy consistent with lung cancer on fine needle aspiration or core biopsy

Secondary

MeasureTime frameDescription
Number of diagnostic procedures performed per patient60 days from initial CT Thoraxnumber of invasive procedures used to obtain tissue to achieve diagnosis and/or stage
Proportion of patients who underwent more than one diagnostic procedures60 days from initial CT Thorax
Proportion of patients who underwent Endobronchial Ultrasound (EBUS)60 days from initial CT Thorax

Contacts

Primary ContactMohammed Ahmed, Dr
jamaleldeen@gmail.com0035391524222

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026